Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2022-03-15 (4 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLIERS-LE-BEL (95400), Val-d'Oise
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DU MARCHE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU MARCHE is a French company
founded 4 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLIERS-LE-BEL (95400),
this company of category PME
shows in 2025 a net income positive of 44 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU MARCHE (SIREN 910888973)
Indicator
2025
2024
2023
Revenue
N/C
N/C
N/C
Net income
44 233 €
87 565 €
77 097 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DU MARCHE generates positive net income of 44 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2025: 77 k€ -> 44 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
44 233 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 101%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 33%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
100.751%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
33.111%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU MARCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
2025
Debt ratio
346.634
163.049
100.751
Financial autonomy
15.48
26.942
33.111
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
100.752025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-9 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE DU MARCHE (100.75) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
33.11%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of SELARL PHARMACIE DU MARCHE (33.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 123.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
123.945
Liquidity indicators evolution SELARL PHARMACIE DU MARCHE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
2025
Liquidity ratio
108.586
133.49
123.945
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
123.942025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch
In 2025, the liquidity ratio of SELARL PHARMACIE DU MARCHE (123.94) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELARL PHARMACIE DU MARCHE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DU MARCHE is estimated at
702 646 €
(range 476 819€ - 1 102 549€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
476k€702k€1102k€
702 646 €Range: 476 819€ - 1 102 549€
NAF 5 année 2025
Valuation method used
Net Income Multiple
44 233 €
×
15.9x
=702 646 €
Range: 476 819€ - 1 102 549€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU MARCHE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU MARCHE
What is the revenue of SELARL PHARMACIE DU MARCHE ?
The revenue of SELARL PHARMACIE DU MARCHE is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DU MARCHE profitable?
Yes, SELARL PHARMACIE DU MARCHE generated a net profit of 44 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DU MARCHE ?
The headquarters of SELARL PHARMACIE DU MARCHE is located in VILLIERS-LE-BEL (95400), in the department Val-d'Oise.
Where to find the tax return of SELARL PHARMACIE DU MARCHE ?
The tax return of SELARL PHARMACIE DU MARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU MARCHE operate?
SELARL PHARMACIE DU MARCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart